EF
SUPN icon

Empowered Funds’s Supernus Pharmaceuticals SUPN Stock Holding History

Empowered Funds’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264K Buy
+5,107
New +$260K ﹤0.01% 1883
2025
Q2 		– Sell
-48,045
Closed -$1.57M – 1848
2025
Q1 		$1.57M Buy
48,045
+6,619
+16% +$235K 0.02% 844
2024
Q4 		$1.5M Buy
+41,426
New +$1.46M 0.02% 840
2024
Q1 		– Sell
-26,350
Closed -$763K – 1439
2023
Q4 		$763K Buy
+26,350
New +$699K 0.02% 874
2023
Q3 		– Sell
-52,192
Closed -$1.57M – 1265
2023
Q2 		$1.57M Sell
52,192
-72,286
-58% -$2.53M 0.06% 489
2023
Q1 		$4.51M Buy
+124,478
New +$4.79M 0.27% 113

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return